Mirvaso TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: brimonidine
Brand name
(ARTG)
: MIRVASO brimonidine 3.3 mg/g (as tartrate) gel tubeDownload the Consumer Medicine Information Leaflet
Download consumer medicine information leaflet (pdf) from the Therapeutic Goods Administration (TGA) website
What this medicine is used for
(ARTG)
MIRVASO is indicated for the treatment of facial erythema of rosacea in adult patients
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Gel
- Topical
- White to light yellow opaque gel
Storage conditions
(ARTG)
- Store below 25 degrees Celsius
- Do not Freeze
- Shelf lifetime is 2 Years.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is
- 10 g pack
- 2 g Physician's sample pack pack
- 30 g pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient brimonidine
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems
